[1] SMITHERMAN H,STARK A R,BHUTANI V K.Early recognition of neonatal hyperbilirubinemia and its emergent management[J].Semin Fetal Neonatal Med,2006,11(3):214-224. [2] 薛雷,王俊杰,轩海华.新生儿ABO溶血病试验结果与日龄的关系分析[J].实验与检验医学,2020,38(5):976-978. [3] 邵肖梅,主编.实用新生儿学[M].北京:人民卫生出版社,2011. [4] 中华医学会儿科学分会新生儿学组,《中华儿科杂志》编辑委员会.新生儿高胆红素血症诊断和治疗专家共识[J].中华儿科杂志,2014,52(10):745-748. [5] 尚红,王毓三,申子瑜, 主编.全国临床检验操作规程[M].北京:人民卫生出版社,2014:139-141. [6] CAO H,WU R,HAN M,et al.Oral administration of Chinese herbal medicine during gestation period for preventing hemolytic disease of the newborn due to ABO incompatibility:a systematic review of randomized controlled trials[J].PLoS One,2017,12(7):e0180746. [7] 蔡大凤,荣成智,秦雪,等.新生儿溶血病患儿的实验结果及相关因素分析[J].检验医学与临床,2020,17(14):2000-2003. [8] 陈静思,裘晓乐.530例新生儿溶血病检测及危险因素分析[J].中国妇幼保健,2020,35(24):4758-4760. [9] 蔡莹,魏建波,金红华,等.血清学试验在诊断新生儿ABO溶血病中的意义[J].中国卫生检验杂志,2013,23(16):3241-3243. [10] 曾月婷,梁结玲,莫水群,等.新生儿溶血病的血清学诊断试验结果研究[J].中国城乡企业卫生,2020,35(5):99-101. [11] 陈卓瑶,邓秋连,黄映红,等.溶血三项检测血清总胆红素及IgG抗体效价与新生儿ABO溶血病的关系探讨[J].新疆医科大学学报,2020,43(8):1069-1072. [12] MAISONNEUVE E.,C.TOLY-NDOUR,J.M.JOUANNIC.Postponing early intrauterine transfusion with intravenous immunoglobulin treatment:the PETIT study on severe hemolytic disease of the fetus and newborn[J].Am J Obstet Gynecol, 2019,220(3):288. |